Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4Gynecologic 1

Conditions

Uterine Cervical Neoplasms 4Stomach Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Lymphatic Metastasis 1Hypoxia 1Endometrial Neoplasms 1Carcinoma, Ovarian Epithelial 1Bile Duct Neoplasms 1

Interventions

pembrolizumab 27Cyclophosphamide 14Gemcitabine 13fludarabine 11Carboplatin 10aldesleukin 9Trastuzumab 9Specimen Handling 9Nivolumab 9Magnetic Resonance Spectroscopy 8Biopsy 8olaparib 7Cisplatin 7Paclitaxel 6palbociclib 5atezolizumab 5Taxes 5Early Intervention, Educational 5Oxaliplatin 4Methods 4Irinotecan 4Drug Therapy 4Docetaxel 4Cetuximab 4Capecitabine 4Bevacizumab 4Albumin-Bound Paclitaxel 4talazoparib 3spartalizumab 3pertuzumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic Neoplasms × Positron Emission Tomography Computed Tomography × Gynecologic × Clear all
NCT05172310 2021-12-29

PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI

Karolinska University Hospital

Phase 1 Recruiting
410 enrolled
GastrointestinalGynecologic

Carcinoma, Ovarian Epithelial, Bile Duct Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡